CBSA Fireside Chat | Punctuate Cell Therapy Research with Essent Biologics

Our Executive Director, Corey Stone, was recently interviewed by CBSA to share how Essent Biologics is setting a new standard in human-derived biomaterials and biology data for research and contributing to Colorado’s rapidly growing life sciences community. Ethan Mann, Ph.D., MBA, Chief Executive Officer of Validus Cellular Therapeutics, Inc. led the discussion touching on a range of topics including human biomaterials, mesenchymal stem cell therapy, drug development, and more. Thank you to our sponsor AlloSource!